4 Oppenheimer August Best Idea Stocks to Buy
Oppenheimer's portfolio strategy team has combed through the universe of stocks they cover and found a group that falls into the favorable category when it comes to the firm's quantitative screens.
Oppenheimer's portfolio strategy team has combed through the universe of stocks they cover and found a group that falls into the favorable category when it comes to the firm's quantitative screens.
One thing people tend to forget, except for certain activist investors maybe, is that Apple has a gigantic amount of cash, the majority of which is stored outside of the United States.
Now is the time to really review portfolios and replace momentum winners with earnings growth leaders. The Cowen Focus Call stocks are just the ticket.
24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term and long-term potential.
24/7 Wall St. screened the Merrill Lynch list of Buy-rated stocks with a 90-day price and volume breakout for those that make sense now as the market seems to be hitting a wall.
The research team at Jefferies is focused each week on finding good value stock calls, and it makes sense for investors in an increasing risky and expensive market to rotate to solid value ideas.
A new research report from JPMorgan stresses that the energy downturn could last the rest of 2015 and well into 2016. The question is could now be the time to be buying?
These industrial stocks are perfect for long-term growth portfolios. They pay solid dividends, are growing their businesses and are returning capital to shareholders.
In a new report, UBS made changes in the firm's Equity Focus list and updated other positions.
In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech companies could be targeted for buyouts.
SunTrust Robinson Humphrey handicaps some of the upcoming events for stocks in the firm's coverage universe that have potential market-moving clinical and FDA catalysts during the remainder of 2015.
A new comprehensive research report from Merrill Lynch takes a hard look at stocks that can benefit as energy investors wait for an increase in spot prices.
Jefferies analysts are very bullish on four U.S. stocks that they think are outstanding buys now, two of which are total contrarian calls.
ThinkstockAs we have been expecting, as the second quarter earnings reporting period starts to come to a close, the windows at public companies for insiders to make transactions are starting to open again. After…
ThinkstockNothing like earnings season coming around to buy stock if you are an insider and your company happens to disappoint. While most of the S&P 500 companies have reported as August begins, some of…
ThinkstockFor the most part, unless you were way over-weighted to energy, large cap and mega cap stocks did reasonably well for investors this year. At the end of 2014 Savita Subramanian and her top…
ThinkstockThere is one obvious result that always starts to spell the end of a momentum phase in the stock market. When a crowded momentum stock beats earnings estimates and guides higher but still gets…
ThinkstockAlmost any way you look at it, the long stock market run looks like it is starting to hit a wall. The commodity market from oil to gold has been hammered, the dollar has…
ThinkstockWhile the market has had a nice pair of back-to-back rally days, many investors are starting to be concerned on valuations again. That’s the time it makes sense to look at value stocks and…
ThinkstockAll of the major indices rebalance their share weightings on a regular basis as their components change in share price and in market capitalization. Generally speaking on index weightings with true rebalances, market cap…